Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul L Shaffer

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Journal of Pharmacology and Experimental Therapeutics|August 4, 2022
Modulation of Ligand-Gated Glycine Receptors Via Functional Monoclonal AntibodiesJeffrey R Simard, Klaus Michelsen, Yan Wang, et al.
Nature Structural & Molecular Biology|December 20, 2016
Crystal structures of human glycine receptor α3 bound to a novel class of analgesic potentiatorsXin Huang, Paul L Shaffer, Shawn Ayube, et al.
Communications Biology|August 5, 2022
Structure of human spermine oxidase in complex with a highly selective allosteric inhibitorElsie Diaz, Suraj Adhikary, Armand W J W Tepper, et al.
Journal of Medicinal Chemistry|December 22, 2016
The Discovery and Hit-to-Lead Optimization of Tricyclic Sulfonamides as Potent and Efficacious Potentiators of Glycine ReceptorsHoward Bregman, Jeffrey R Simard, Kristin L Andrews, et al.
Molecular Cancer Therapeutics|March 3, 2026
JNJ-79032421, a Novel Membrane-restricted Mesothelin-targeting T-cell-engaging Bispecific Antibody for the Treatment of Mesothelin-positive CancersKarine Smans, Thomas Nesspor, Sabine De Breucker, et al.
Journal of Medicinal Chemistry|January 15, 2015
Discovery of 1H-pyrazol-3(2H)-ones as potent and selective inhibitors of protein kinase R-like endoplasmic reticulum kinase (PERK)Adrian L Smith, Kristin L Andrews, Holger Beckmann, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2012
Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitorsEmily A Peterson, Alessandro A Boezio, Paul S Andrews, et al.
Blood|June 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemiasMin Chul Kwon, Jan Willem Thuring, Olivier Querolle, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2023
Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammationHolger Babbe, Thomas B Sundberg, Mark Tichenor, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Pharmacology and Experimental Therapeutics|August 4, 2022
Modulation of Ligand-Gated Glycine Receptors Via Functional Monoclonal AntibodiesJeffrey R Simard, Klaus Michelsen, Yan Wang, et al.
Nature Structural & Molecular Biology|December 20, 2016
Crystal structures of human glycine receptor α3 bound to a novel class of analgesic potentiatorsXin Huang, Paul L Shaffer, Shawn Ayube, et al.
Communications Biology|August 5, 2022
Structure of human spermine oxidase in complex with a highly selective allosteric inhibitorElsie Diaz, Suraj Adhikary, Armand W J W Tepper, et al.
Journal of Medicinal Chemistry|December 22, 2016
The Discovery and Hit-to-Lead Optimization of Tricyclic Sulfonamides as Potent and Efficacious Potentiators of Glycine ReceptorsHoward Bregman, Jeffrey R Simard, Kristin L Andrews, et al.
Molecular Cancer Therapeutics|March 3, 2026
JNJ-79032421, a Novel Membrane-restricted Mesothelin-targeting T-cell-engaging Bispecific Antibody for the Treatment of Mesothelin-positive CancersKarine Smans, Thomas Nesspor, Sabine De Breucker, et al.
Journal of Medicinal Chemistry|January 15, 2015
Discovery of 1H-pyrazol-3(2H)-ones as potent and selective inhibitors of protein kinase R-like endoplasmic reticulum kinase (PERK)Adrian L Smith, Kristin L Andrews, Holger Beckmann, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2012
Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitorsEmily A Peterson, Alessandro A Boezio, Paul S Andrews, et al.
Blood|June 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemiasMin Chul Kwon, Jan Willem Thuring, Olivier Querolle, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2023
Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammationHolger Babbe, Thomas B Sundberg, Mark Tichenor, et al.
Pageof 2